Magnesium ions outside nerve cells block NMDA receptors in a voltage-dependent way, preventing excessive calcium entry and overstimulation of neurons, which helps protect the brain from damage during high activity or injury.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether therapeutic magnesium administration in humans with acute brain injury or epilepsy reduces excitotoxic neuronal death via NMDAR blockade, compared to placebo, by synthesizing clinical outcomes from randomized trials.
A systematic review and meta-analysis of all randomized controlled trials in humans with acute ischemic stroke or traumatic brain injury comparing intravenous magnesium sulfate (1–2 g/h for 24–48 h) versus placebo, with primary outcomes of 90-day mortality, neurological deficit scores (NIHSS), and biomarkers of excitotoxicity (e.g., serum S100B, NSE).
Whether acute magnesium infusion in humans reduces NMDAR-mediated excitotoxicity during stroke, measured by neuroimaging and biomarkers, compared to placebo.
A double-blind, placebo-controlled trial of 300 adults with acute ischemic stroke (onset <4.5 h), randomized to IV magnesium sulfate (1.5 g/h for 24 h) or saline, with primary outcomes: change in diffusion-weighted MRI lesion volume, serum glutamate levels, and 90-day modified Rankin Scale score.
Whether chronic low serum magnesium levels predict increased incidence of epilepsy or migraine in a general population, independent of confounders.
A prospective cohort of 10,000 adults aged 30–65 with baseline serum magnesium measured and followed for 10 years, with incident epilepsy and migraine diagnosed via standardized neurological evaluation, adjusting for diet, renal function, and medication use.
Whether patients with refractory epilepsy have lower cerebrospinal fluid magnesium levels compared to controls without seizures.
A case-control study comparing CSF magnesium concentrations in 50 patients with drug-resistant temporal lobe epilepsy and 50 matched controls without neurological disease, measured via lumbar puncture and standardized HPLC.
Whether serum magnesium levels correlate with NMDAR-mediated cortical excitability in healthy adults, measured by transcranial magnetic stimulation.
A cross-sectional study of 200 healthy adults aged 20–50, measuring serum magnesium and cortical excitability via paired-pulse TMS (SICI and ICF), controlling for age, sex, and vitamin B6 status.